Leroy Ronald Langham's Insider Trades & SAST Disclosures
Leroy Ronald Langham's most recent trade in Enhabit Inc was a trade of 7,092 Common Stock done at an average price of $8.0 . Disclosure was reported to the exchange on March 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Leroy Ronald Langham.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enhabit Inc | Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Grant, award, or other acquisition of securities at price $ 8.02 per share. | 06 Mar 2025 | 7,092 | 58,541 | - | 8.0 | 56,878 | Common Stock |
| Enhabit Inc | Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.02 per share. | 06 Mar 2025 | 2,377 | 56,164 | - | 8.0 | 19,064 | Common Stock |
| Enhabit Inc | Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.37 per share. | 01 Mar 2025 | 3,041 | 51,449 | - | 8.4 | 25,453 | Common Stock |
| Enhabit Inc | Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.26 per share. | 25 Feb 2025 | 334 | 54,490 | - | 8.3 | 2,759 | Common Stock |
| Enhabit Inc | Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.81 per share. | 01 Jan 2025 | 1,031 | 55,480 | - | 7.8 | 8,052 | Common Stock |
| Enhabit Inc | Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.81 per share. | 01 Jan 2025 | 656 | 54,824 | - | 7.8 | 5,123 | Common Stock |
| Enhabit Inc | Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.75 per share. | 01 Jul 2024 | 673 | 56,491 | - | 8.8 | 5,889 | Common Stock |
| Enhabit Inc | Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Grant, award, or other acquisition of securities at price $ 8.81 per share. | 01 Mar 2024 | 15,027 | 57,798 | - | 8.8 | 132,388 | Common Stock |
| Enhabit Inc | Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Sale of securities on an exchange or to another person at price $ 8.81 per share. | 01 Mar 2024 | 634 | 57,164 | - | 8.8 | 5,586 | Common Stock |
| Enhabit Inc | Leroy Ronald Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.49 per share. | 24 Feb 2024 | 333 | 42,771 | - | 9.5 | 3,160 | Common Stock |
| Enhabit Inc | Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.49 per share. | 24 Feb 2024 | 181 | 43,104 | - | 9.5 | 1,718 | Common Stock |
| Enhabit Inc | Leroy Ronald Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.35 per share. | 01 Jan 2024 | 1,043 | 43,285 | - | 10.3 | 10,795 | Common Stock |
| Enhabit Inc | Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Purchase of securities on an exchange or from another person at price $ 11.99 per share. | 18 May 2023 | 10,000 | 44,328 | - | 12.0 | 119,900 | Common Stock |
| Enhabit Inc | Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 6,373 | 32,734 | - | 0 | Common Stock | |
| Enhabit Inc | Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 1,594 | 34,328 | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges